Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer (JO19380): Evaluation of long-term treatment cases

Atsushi Sato, Toshihiko Doi, Narikazu Boku, Ken Kato, Yoshito Komatsu, Kensei Yamaguchi, Kei Muro, Yasuo Hamamoto, Wasaburo Koizumi, Nobuyuki Mizunuma, Hiroya Takiuchi

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer (JO19380): Evaluation of long-term treatment cases'. Together they form a unique fingerprint.

Medicine & Life Sciences